Abstract:The misfolding and aggregation of human islet amyloid polypeptide (hIAPP or amylin) into small oligomers and large amyloid fibrils is believed to be responsible for the dysfunction and death of pancreatic β-cells in diabetes type II. However, rat IAPP (rIAPP), which differs from the hIAPP by only 6 of 37 residues, lacks the ability to form amyloid fibrils and to induce cell death. Little is known about the cross-sequence interactions and cross-seeding structures between hIAPP and rIAPP peptides. Herein using explicit-solvent molecular dynamics (MD) simulations, we modeled and simulated different heteroassemblies formed by the amyloidogenic hIAPP and the nonamyloidogenic rIAPP peptides. Simulations showed that the U-shaped hIAPP monomer and oligomers can interact with conformationally similar rIAPP to form stable complexes and to coassemble into heterogeneous structures. Stable heterointeractions between hIAPP and rIAPP were shown to arise from hydrophobic contacts and hydrogen bonds at the interface, particularly at N- and C-terminal β-sheet regions. Because of the enhanced interpeptide interactions at the interface, upon binding to hIAPP oligomers, the β-sheet population of rIAPP was greatly increased as compared to that of rIAPP alone. More importantly, the conformational energies of rIAPP monomers at the bound state were observed to be consistently higher than those of rIAPP monomers at the unbound state. However, rIAPP monomers enable one to adopt different conformations and follow different pathways for associating with hIAPP from the high energy of the bound state to the low energy of the unbound state, without encountering any large and abrupt energy barrier. In parallel, AFM study of cross-aggregation of hIAPP and rIAPP provided additional evidence that hIAPP can seed with rIAPP to form hybrid fibrils at all concentrations similar to pure hIAPP fibrils. This work demonstrates the existence of cross-interactions between the two different IAPP peptides, which provides an improved fundamental understanding of the cross-seeding of different amyloid sequences toward amyloid aggregation and toxicity mechanisms.

Short Peptide Segment and Insulin Co-Assembly Forms Cytotoxic Oligomers

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides.

Clues to the Design of Aggregation-Resistant Insulin from Proline Scanning of Highly Amyloidogenic Peptides Derived from the N-Terminal Segment of the A-Chain

Study of Insulin Aggregation and Fibril Structure under Different Environmental Conditions

Stabilities and Structures of Islet Amyloid Polypeptide (Iapp(22-28)) Oligomers: from Dimer to 16-Mer

Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation.

Mechanistic modeling of amyloid oligomer and protofibril formation in bovine insulin

Deciphering the Molecular Dance: Exploring the Dynamic Interplay Between Mouse Insulin B9-23 Peptides and Their Variants

Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties

Supramolecular Assembly of Cp1-11 Peptide and Insulin for Rapid-Acting Formulation

Atomic resolution structure of full-length human insulin fibrils

Molecular Insights into the Oligomerization Dynamics and Conformations of Amyloidogenic and Non-Amyloidogenic Amylin from Discrete Molecular Dynamics Simulations

Structure and Thermodynamics of Amylin Dimer Studied by Hamiltonian-Temperature Replica Exchange Molecular Dynamics Simulations

Converting the Amyloidogenic Islet Amyloid Polypeptide into a Potent Nonaggregating Peptide Ligand by Side Chain-to-Side Chain Macrocyclization

Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation.

Beyond amino acid sequence: disulfide bonds and the origins of the extreme amyloidogenic properties of insulin's H‐fragment

Influence of Hydrophobicity on the Surface-Catalyzed Assembly of the Islet Amyloid Polypeptide

Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP

Anion–Induced Amyloid Fibrillation of Human Insulin In vitro

Characterizing the assembly behaviors of human amylin: a perspective derived from C-terminal variants.